Keith A. Joiner
#142,163
Most Influential Person Now
Researcher
Keith A. Joiner's AcademicInfluence.com Rankings
Keith A. Joinerengineering Degrees
Engineering
#5374
World Rank
#6629
Historical Rank
Electrical Engineering
#1489
World Rank
#1583
Historical Rank
Keith A. Joinercomputer-science Degrees
Computer Science
#6887
World Rank
#7254
Historical Rank
Computational Linguistics
#1284
World Rank
#1298
Historical Rank
Machine Learning
#2379
World Rank
#2409
Historical Rank
Artificial Intelligence
#2662
World Rank
#2703
Historical Rank
Download Badge
Engineering Computer Science
Keith A. Joiner's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Keith A. Joiner Influential?
(Suggest an Edit or Addition)Keith A. Joiner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. (1990) (460)
- The human mannose-binding protein functions as an opsonin (1989) (437)
- The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. (1994) (391)
- The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. (1994) (387)
- Complement evasion by bacteria and parasites. (1988) (332)
- Association of host cell endoplasmic reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole membrane: a high affinity interaction. (1997) (326)
- Toxoplasma gondii Sequesters Lysosomes from Mammalian Hosts in the Vacuolar Space (2006) (315)
- Toxoplasma gondii Exploits Host Low-Density Lipoprotein Receptor-Mediated Endocytosis for Cholesterol Acquisition (2000) (289)
- The parasitophorous vacuole membrane surrounding Plasmodium and Toxoplasma: an unusual compartment in infected cells. (1998) (276)
- CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. (1989) (250)
- Safe haven: the cell biology of nonfusogenic pathogen vacuoles. (1997) (241)
- The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm (1994) (230)
- Perspectives Series: Host/Pathogen Interactions (1997) (226)
- Complement and bacteria: chemistry and biology in host defense. (1984) (216)
- The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane (2001) (210)
- Golgi biogenesis in Toxoplasma gondii (2002) (187)
- Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan (1988) (186)
- Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. (1986) (172)
- Four distinct pathways of hemoglobin uptake in the malaria parasite Plasmodium falciparum (2008) (164)
- Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. (1990) (164)
- Tandemly repeated genes encode nucleoside triphosphate hydrolase isoforms secreted into the parasitophorous vacuole of Toxoplasma gondii. (1994) (159)
- Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. (1988) (156)
- Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide (1989) (144)
- Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies. (1987) (143)
- Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. (2003) (143)
- Secretory traffic in the eukaryotic parasite Toxoplasma gondii (2002) (141)
- Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor (1996) (140)
- Targeting to rhoptry organelles of Toxoplasma gondii involves evolutionarily conserved mechanisms. (2000) (134)
- Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. (1989) (133)
- Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm (1992) (132)
- Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo (1987) (130)
- Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. (1995) (127)
- The Protozoan Parasite Toxoplasma gondii Targets Proteins to Dense Granules and the Vacuolar Space Using Both Conserved and Unusual Mechanisms (1998) (124)
- Kinetics and pattern of organelle exocytosis duringToxoplasma gondii/host-cell interaction (2004) (123)
- C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. (1986) (119)
- Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. (1983) (115)
- Toxoplasma gondii: a protozoan for the nineties (1993) (114)
- Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule (1983) (113)
- The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes (1989) (112)
- The Cathepsin B of Toxoplasma gondii,Toxopain-1, Is Critical for Parasite Invasion and Rhoptry Protein Processing* (2002) (108)
- Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen (1984) (107)
- Selective Disruption of Phosphatidylcholine Metabolism of the Intracellular Parasite Toxoplasma gondii Arrests Its Growth* (2005) (101)
- Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. (1985) (101)
- Interaction of human mannose-binding protein with Mycobacterium avium. (1997) (94)
- A soluble secretory protein of the intracellular parasite Toxoplasma gondii associates with the parasitophorous vacuole membrane through hydrophobic interactions. (1994) (93)
- AP-1 in Toxoplasma gondii Mediates Biogenesis of the Rhoptry Secretory Organelle from a Post-Golgi Compartment* (2003) (90)
- Host cell lipids control cholesteryl ester synthesis and storage in intracellular Toxoplasma (2005) (89)
- The function of antibody and complement in the lysis of bacteria. (1987) (86)
- An analysis of the Candida albicans genome database for soluble secreted proteins using computer‐based prediction algorithms (2003) (84)
- Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases. (1988) (83)
- Evolving to a new service-dominant logic for health care (2016) (81)
- Laminin enhances binding of Toxoplasma gondii tachyzoites to J774 murine macrophage cells (1992) (80)
- Laminin on Toxoplasma gondii mediates parasite binding to the beta 1 integrin receptor alpha 6 beta 1 on human foreskin fibroblasts and Chinese hamster ovary cells (1992) (80)
- Induced Activation of the Toxoplasma gondiiNucleoside Triphosphate Hydrolase Leads to Depletion of Host Cell ATP Levels and Rapid Exit of Intracellular Parasites from Infected Cells* (1998) (79)
- Are rhoptries in Apicomplexan parasites secretory granules or secretory lysosomal granules? (2004) (78)
- Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody. (1985) (75)
- Targeted Reduction of Nucleoside Triphosphate Hydrolase by Antisense RNA Inhibits Toxoplasma gondii Proliferation* (1999) (75)
- Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide. (1984) (73)
- Differential sorting and post-secretory targeting of proteins in parasitic invasion. (2000) (72)
- Strategies of obligate intracellular parasites for evading host defences. (1991) (71)
- Antibiotic levels in infected and sterile subcutaneous abscesses in mice. (1981) (69)
- Interactions of human mannose-binding protein with lipoteichoic acids (1996) (69)
- Constitutive Calcium-independent Release of Toxoplasma gondii Dense Granules Occurs through the NSF/SNAP/SNARE/Rab Machinery* (1999) (68)
- Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X. (1987) (67)
- Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum. (1989) (66)
- A study of optimal reaction conditions for an assay of the human alternative complement pathway. (1983) (65)
- Cloning of a cDNA encoding the dense granule protein GRA3 from Toxoplasma gondii. (1994) (65)
- Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes. (1989) (65)
- Upstream elements required for expression of nucleoside triphosphate hydrolase genes of Toxoplasma gondii. (1998) (65)
- A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF (1993) (64)
- The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. (1983) (63)
- Toxoplasma gondii Rab5 enhances cholesterol acquisition from host cells (2002) (63)
- Toxoplasma gondii tachyzoites possess an unusual plasma membrane adenosine transporter. (1995) (62)
- On the biogenesis of lipid bodies in ancient eukaryotes: synthesis of triacylglycerols by a Toxoplasma DGAT1-related enzyme. (2004) (62)
- Actin is required for endocytic trafficking in the malaria parasite Plasmodium falciparum (2007) (61)
- Pleiotropic effect due to targeted depletion of secretory rhoptry protein ROP2 in Toxoplasma gondii (2003) (60)
- Isolation, cDNA sequences, and biochemical characterization of the major cyclosporin-binding proteins of Toxoplasma gondii. (1994) (60)
- The expression and distribution of dense granule proteins in the enteric (Coccidian) forms of Toxoplasma gondii in the small intestine of the cat. (1999) (59)
- Traffic jams: protein transport in Plasmodium falciparum. (2000) (59)
- The expression of Toxoplasma proteins in Neospora caninum and the identification of a gene encoding a novel rhoptry protein. (1997) (58)
- Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. (1985) (57)
- Neutral lipid synthesis and storage in the intraerythrocytic stages of Plasmodium falciparum. (2004) (57)
- Toxoplasma gondii infection induces apoptosis in noninfected macrophages: role of nitric oxide and other soluble factors (2007) (56)
- Toxoplasma gondii: mechanism of resistance to complement-mediated killing. (1989) (56)
- Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. (1983) (55)
- A Family of Aspartic Proteases and a Novel, Dynamic and Cell‐Cycle‐Dependent Protease Localization in the Secretory Pathway of Toxoplasma gondii (2007) (55)
- Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity. (1985) (54)
- Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. (1986) (53)
- Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma. (2003) (52)
- The Plasmodium falciparum Vps4 homolog mediates multivesicular body formation (2004) (52)
- Basis for substrate specificity of the Toxoplasma gondii nucleoside triphosphate hydrolase. (1998) (52)
- Peculiarities of Host Cholesterol Transport to the Unique Intracellular Vacuole Containing Toxoplasma (2005) (52)
- Targeting and Subcellular Localization of Toxoplasma gondii Catalase (2000) (51)
- Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice (1982) (51)
- gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes (1985) (50)
- Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa (1986) (50)
- A quantitative model for subcutaneous abscess formation in mice. (1980) (48)
- Traffic to the Malaria Parasite Food Vacuole (2007) (48)
- A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4. (1984) (48)
- Toxoplasma gondii Rab6 Mediates a Retrograde Pathway for Sorting of Constitutively Secreted Proteins to the Golgi Complex* (2003) (47)
- Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules (1983) (47)
- Developmentally regulated expression by Trypanosoma cruzi of molecules that accelerate the decay of complement C3 convertases. (1988) (47)
- Comparative efficacy of 10 antimicrobial agents in experimental infections with Bacteroides fragilis. (1982) (47)
- Differential Effects of Quinoline Antimalarials on Endocytosis in Plasmodium falciparum (2008) (46)
- Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus. (1987) (45)
- Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology (1997) (44)
- Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. (1983) (43)
- Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. (1985) (42)
- C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae. (1987) (40)
- Toxoplasma gondii is capable of exogenous folate transport. A likely expansion of the BT1 family of transmembrane proteins. (2005) (40)
- Toxopain-1 Is Critical for Infection in a Novel Chicken Embryo Model of Congenital Toxoplasmosis (2004) (40)
- Dictyostelium discoideum mutants with conditional defects in phagocytosis (1994) (39)
- Serum complement activation in central nervous system disease in Sjögren's syndrome. (1988) (38)
- Rhoptry lipids and parasitophorous vacuole formation: a slippery issue. (1991) (37)
- Parasite–host cell interactions in toxoplasmosis: new avenues for intervention? (2001) (36)
- Transmembrane Domain Modulates Sorting of Membrane Proteins in Toxoplasma gondii* (2004) (36)
- Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate. (1986) (35)
- Endocytosis in different lifestyles of protozoan parasitism: role in nutrient uptake with special reference to Toxoplasma gondii. (2001) (34)
- Novel roles for ATP‐binding cassette G transporters in lipid redistribution in Toxoplasma (2010) (34)
- Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing. (1987) (33)
- Eosin B as a Novel Antimalarial Agent for Drug-Resistant Plasmodium falciparum (2006) (32)
- Characterization of host cell-derived membrane proteins of the vacuole surrounding different intracellular forms of Trypanosoma cruzi in J774 cells. Evidence for phagocyte receptor sorting during the early stages of parasite entry. (1991) (32)
- Faculty Opinions recommendation of Identification of a stomatin orthologue in vacuoles induced in human erythrocytes by malaria parasites. A role for microbial raft proteins in apicomplexan vacuole biogenesis. (2003) (32)
- Outsourcing in the Healthcare Industry: Information Technology, Intellectual Property, and Allied Aspects (2009) (32)
- Toxoplasma gondii ADP-ribosylation Factor 1 Mediates Enhanced Release of Constitutively Secreted Dense Granule Proteins* (2001) (31)
- Cytoplasmic tail motifs mediate endoplasmic reticulum localization and export of transmembrane reporters in the protozoan parasite Toxoplasma gondii (2000) (31)
- IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111 (1985) (31)
- Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. (1982) (31)
- Host factors in the formation of abscesses. (1980) (30)
- C3b binding, but not its breakdown, is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from Salmonellae. (1986) (30)
- Oxidosqualene cyclase inhibitors as antimicrobial agents. (2003) (29)
- Membrane attack complex of complement in rheumatoid synovial tissue demonstrated by immunofluorescent microscopy. (1986) (27)
- Experimental and control systems studies of plasma fibrinogen regulation in rabbits. (1969) (26)
- Coinfection of fibroblasts with Coxiella burnetti and Toxoplasma gondii: to each their own. (2000) (26)
- Toxoplasma gondii: are host cell adenosine nucleotides a direct source for purine salvage? (2000) (26)
- Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa (1989) (26)
- Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis. (1983) (25)
- A Molecular Docking Strategy Identifies Eosin B as a Non-active Site Inhibitor of Protozoal Bifunctional Thymidylate Synthase-Dihydrofolate Reductase* (2003) (24)
- Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro. (1983) (24)
- Developmentally‐Regulated Virulence Factors of Trypanosoma cruzi and Their Relationship to Evasion of Host Defences 1 (1993) (23)
- Membrane-protein traffic in pathogen-infected cells. (1997) (23)
- Targeting the secretory pathway of Toxoplasma gondii. (1997) (22)
- Terminal Complement Complexes (SC5b‐9) in Cerebrospinal Fluid in Autoimmune Nervous System Diseases (1988) (21)
- Role of the O-Antigen of Lipopolysaccharide in Salmonella in Protection against Complement Action (1990) (19)
- Structure and Function of the Parasitophorous Vacuole Membrane Surrounding Toxoplasma gondii (1994) (18)
- Physician Practice Style and Healthcare Costs: Evidence from Emergency Departments (2017) (18)
- Localization of azithromycin in Toxoplasma gondii-infected cells (1994) (18)
- Quantitation of activation of the human terminal complement pathway by ELISA. (1985) (17)
- Protein-targeting determinants in the secretory pathway of apicomplexan parasites. (2000) (17)
- Improving Clinical Productivity in the Academic Setting: A Novel Incentive Plan Based on Utility Theory (2006) (16)
- The role of complement in host resistance to bacteria (2005) (16)
- Timing of Revenue Streams from Newly Recruited Faculty: Implications for Faculty Retention (2007) (14)
- Relative Efficacy of β-Lactam Antimicrobial Agents in Two Animal Models of Infections Involving Bacteroides fragilis (1983) (14)
- Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen. (1989) (14)
- A Strategy for Allocating Central Funds to Support New Faculty Recruitment (2005) (14)
- Selection based on the expression of antisense hypoxanthine-xanthine-guanine-phosphoribosyltransferase RNA in Toxoplasma gondii. (2000) (14)
- The biologic activity of mast cell granules. IV. The effect of complement depletion on rat cutaneous late phase reactions. (1983) (14)
- En route to the vacuole: Tracing the secretory pathway of Toxoplasma gondii (1999) (13)
- Strategies for Defining Financial Benchmarks for the Research Mission in Academic Health Centers (2005) (13)
- The effect of cobra venom factor on alternative pathway hemolytic activity in mice. (1980) (12)
- Complement evasion by protozoa. (1989) (11)
- Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium. (1989) (11)
- Supporting the Academic Mission in an Era of Constrained Resources: Approaches at the University of Arizona College of Medicine (2008) (11)
- Toxoplasma gondii: conserved protein machinery in an unusual secretory pathway? (2000) (11)
- Complement binding on serum-sensitive and serum-resistant transformants of Neisseria gonorrhoeae: effect of presensitization with a non-bactericidal monoclonal antibody. (1989) (10)
- Antimicrobial therapy of digestive diseases. (1979) (10)
- Cell entry by Toxoplasma gondii: all paths do not lead to success. (1993) (10)
- A sensitive microassay for the murine alternative complement pathway. (1979) (10)
- Studies of antibody and complement function in host defense against bacterial infection. (1987) (10)
- Cell attachment and entry by Toxoplasma gondii. (1991) (10)
- Transfer of tetracycline or clindamycin resistance among strains of Bacteroides fragilis in experimental abscesses. (1984) (10)
- Toxoplasma/host-cell interactions (1996) (10)
- The not-for-profit form and translational research: Kerr revisited? (2005) (9)
- Characterization of protein I from serum-sensitive and serum-resistant transformants of Neisseria gonorrhoeae. (1987) (9)
- Identification of membrane components of Trypanosoma cruzi modulators of complement system. (1988) (9)
- Introduction of Caveolae Structural Proteins into the Protozoan Toxoplasma Results in the Formation of Heterologous Caveolae but Not Caveolar Endocytosis (2012) (9)
- A review of the economics of adult congenital heart disease (2016) (8)
- Role of Complement in Infectious Diseases (1986) (8)
- Resource allocation in academic health centers: creating common metrics. (2011) (8)
- Sponsored-Research Funding by Newly Recruited Assistant Professors: Can It Be Modeled as a Sequential Series of Uncertain Events? (2004) (8)
- Activation of the Alternative Complement Pathway by Blood Culture Isolates of Bacteroides fragilis (1981) (8)
- Phoenix rises, with Tucson's help: establishing the first four-year allopathic program in the nation's fifth largest city. (2007) (7)
- Are Teaching Hospitals Treated Fairly in the Hospital-Acquired Condition Reduction Program? (2018) (7)
- The role of parasites in generating evolutionary novelty. (1993) (7)
- A simple model to optimize resource allocations when expanding the faculty research base: a case study. (2009) (6)
- Plasmodium falciparum: discovery of peroxidase active organelles. (2005) (6)
- Mechanism of bacterial resistance to serum killing (1982) (6)
- Using Utility Theory to Optimize a Salary Incentive Plan for Grant-Funded Faculty (2004) (6)
- CR1 mediates binding of L. major metacyclic promastigotes to human macrophages. (1988) (6)
- Strategies of obligate intracellular parasites for evading host defences (1991) (5)
- The Parasitophorous Vacuole Membrane Surrounding T. Gondii: A Specialized Interface Between Parasite and Cell (1993) (5)
- A Comprehensive Space Management Model for Facilitating Programmatic Research (2008) (5)
- The effect of corticosteroids on subcutaneous abscess formation in the mouse. (1981) (5)
- Evolving to a Service-Dominant Logic for Health (2015) (5)
- Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013 (2018) (5)
- Does Health it Adoption Lead to Better Information or Worse Incentives? (2016) (5)
- Avoiding the winner's curse in faculty recruitment. (2005) (5)
- Functional Competence of Peritoneal Macrophages in Murine Lyme Borreliosis (2004) (5)
- Molecular basis for interactions between parasites and the complement cascade. (1988) (5)
- Integrating geriatrics into clinical training, research training, board certification, and continuing education in infectious diseases: meeting review and commentary. (1999) (4)
- Potassium cyanide protects Escherichia coli from complement killing by the inhibition of C3 convertase activity. (1993) (4)
- Commentary: Evaluating faculty productivity in research: an interesting approach, but questions remain. (2009) (4)
- Molecular Mechanisms in the Antibacterial Action of Complement (1986) (4)
- Integrating geriatrics and subspecialty internal medicine: results of a survey on patient care practices, training, attitudes, and research. (2002) (4)
- Role of serum in stimulation of polymorphonuclear leukocyte, luminol-dependent chemiluminescence by influenza A. (1985) (4)
- Distinguishing moral hazard from access for high-cost healthcare under insurance (2020) (4)
- Perspective: key indicators in academic medicine: a suggested framework for analysis. (2012) (4)
- How Do Hospitals Respond to Payment Incentives? (2019) (3)
- Why do so many surface proteins of trypanosomatids have GPI-anchors? (1991) (3)
- Crowdsourcing Public Health Experiments: A Response to Jonathan Darrow's Crowdsourcing Clinical Trials (2014) (3)
- Lytic rabbit IgG for tissue culture trypomastigotes of Trypanosoma cruzi alters the extent and form of complement deposition. (1989) (3)
- A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition. (1987) (3)
- Supporting research in departments of internal medicine: recommendations for NIH. (2000) (3)
- Indemnifying precaution: economic insights for regulation of a highly infectious disease (2020) (3)
- A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing (2015) (3)
- REGULATION AND CONTROL IN PHYSIOLOGICAL SYSTEMS. (3)
- A Quantitative Model of Calcium and Phosphate Metabolism (1973) (2)
- T-daf: a developmentally regulated complement inhibitor expressed by trypomastigotes of t. Cruzi (1992) (2)
- Mechanisms of stable serum resistance of Neisseria gonorrhoeae (2004) (2)
- A Randomized Experiment of the Split Benefit Health Insurance Reform to Reduce High-Cost, Low-Value Consumption (2014) (2)
- Acute septic complications in gastrointestinal emergencies. (1981) (2)
- Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis. (1982) (2)
- Salmonella and Complement: The Critical Influence of O-Polysaccharide within LPS (1988) (2)
- Structural Aspects of LPS: Role in Evasion of Host Defense Mechanism (1991) (2)
- C3 binding but not its breakdown is affected by the structure of lipopolysaccharide (LPS) on the surface of Salmonellae (1984) (2)
- Scaling and Splitting : new approacheS to health inSurance (2015) (1)
- Physician Incentive Compensation Plans in Academic Medical Centers: The Imperative to Prioritize Value. (2021) (1)
- Mechanism of antibody dependent serum killing of escherichia coli o 111b 4 (1982) (1)
- The effects of hypocomplementemia on rat late-phase reactions (1982) (1)
- LIPID X, A NOVEL INHIBITOR OF ENDOTOXIN (1987) (1)
- Improving students’ performance with time management skills (2021) (1)
- Analyses of the immunoaccessibility of H8 antigen and the functionality of H8 specific monoclonal antibody 10 (2004) (0)
- Comparison of binding of factors B and H to C3b on Salmonellae differing in their O-antigen polysaccharide (O-PS) structure (1986) (0)
- Halogenation and proteolysis of complement component C3 on Salmonella typhimurium during phagocytosis by human neutrophils. (1989) (0)
- Correction (2019) (0)
- Enhanced invasion of mononuclear phagocytes by serum-treated Trypanosoma cruzi is due to Clq. (1988) (0)
- Developmentally regulated expression byTrypanosoma cruzi of molecules thataccelerate thedecayofcomplement C3convertases (1988) (0)
- Complement binding to Leishmania donovani promastigotes (LD) (1986) (0)
- Targeting of proteins in the parasitophorous vacuolar space of Toxoplasma gondii (1997) (0)
- Interaction of complement with Leishmania maior and Trypanosoma cruzi: how they use and how they abuse it (1988) (0)
- Cell Mediated Immunity Against Bacterial Abscess Formation (1985) (0)
- Faculty Opinions recommendation of Hepatocyte growth factor and its receptor are required for malaria infection. (2003) (0)
- Quantitation of Radiolabeled Component Binding to Bacteria (2003) (0)
- Correction (2019) (0)
- Multimeric complement component C 9 is necessary for killing of Escherichia coli J 5 by terminal attack complex C 5 b9 [ poly ( C 9 ) / complement-mediated bacterial killing ] (0)
- ROCKY MOUNTAIN BIOENGINEERING SYMPOSIUM, 10TH ANNUAL, PROCEEDINGS, 1973. (0)
- Different fractional domains in the parasitophorous vacuole membrane of Toxoplasma gondii (1997) (0)
- Brief Reports on All Topics (1981) (0)
- Lipopolysaccharide Size and Distribution Determine Serum Resistance in Salmonella montevideo (1987) (0)
- Complement-mediated bacterial killing and bacterial resistance to complement attack (1985) (0)
- Evaluation of antimicrobial agents in animal models of infections involving bacteroides fragilis (1985) (0)
- MECHANISM OF SERUM RESISTANCE IN BACTERIA Serum (2003) (0)
- Safely unsterile : understanding the anatomical and immunologic niches of placental , urinary and vaginal microbiomes (2016) (0)
- Erratum: (Journal of Clinical Investigation (April 1997) 99:8 (1814- 1817)) (1997) (0)
- Upcoding of hospital admissions in Medicare Part A: Not a Significant issue Now (2020) (0)
- Upcoding of Hospital Admissions: No Longer a Substantial Issue for Medicare (2020) (0)
- Yale Physician-Researcher Keith A. Joiner Appointed Dean of University of Arizona College of Medicine (2004) (0)
- A practical cost-based approach to determining reimbursement rates: a necessary component of effective payment reform (2015) (0)
- Parasites as host cholesterol consumers: The special case of Toxoplasma gondii (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Keith A. Joiner?
Keith A. Joiner is affiliated with the following schools:
